These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16632226)

  • 21. Polyserositis, acute withdrawal, and relapse after abrupt clozapine discontinuation.
    Malhotra S; Franco K; Tomford JW; Iqbal R
    Psychosomatics; 2002; 43(5):418-20. PubMed ID: 12297612
    [No Abstract]   [Full Text] [Related]  

  • 22. Thioridazine withdrawal-induced behavioral deterioration treated with clonidine: two case reports.
    Sovner R
    Ment Retard; 1995 Aug; 33(4):221-5. PubMed ID: 7565144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Repercussions of the withdrawal of thioridazine].
    Buj Alvarez I; Pifarré Paredero J; Idini E; Puigdevall Ruestes M
    Actas Esp Psiquiatr; 2008; 36(3):183-6. PubMed ID: 18478459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for dosing and switching antipsychotics for optimal clinical management.
    Buckley PF; Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experiencing antipsychotic discontinuation: results from a survey of Australian consumers.
    Salomon C; Hamilton B; Elsom S
    J Psychiatr Ment Health Nurs; 2014 Dec; 21(10):917-23. PubMed ID: 25298092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of maintenance use of anticholinergic agents.
    Double DB; Warren GC; Evans M; Rowlands RP
    Acta Psychiatr Scand; 1993 Nov; 88(5):381-4. PubMed ID: 7905226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic discontinuation syndromes.
    Tranter R; Healy D
    J Psychopharmacol; 1998; 12(4):401-6. PubMed ID: 10065916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic withdrawal with remitted schizophrenics: a naturalistic follow-up study.
    Nishikawa T; Hayashi T; Koga I; Uchida Y
    Psychiatry; 2007; 70(1):68-79. PubMed ID: 17492913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic withdrawal-induced relapse predicts future relapses in institutionalized adults with severe intellectual disability.
    Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
    J Clin Psychopharmacol; 2008 Aug; 28(4):401-5. PubMed ID: 18626266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic discontinuation syndromes: a narrative review of the evidence and its integration into Australian mental health nursing textbooks.
    Salomon C; Hamilton B
    Int J Ment Health Nurs; 2014 Feb; 23(1):69-78. PubMed ID: 23211033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hypothesis of oestrogen withdrawal associated psychoses and the paradox of antipsychotic drug-induced hypoestrogenaemia.
    Baptista T; Beaulieu S
    Acta Psychiatr Scand; 2002 Jun; 105(6):473-4; author reply 474. PubMed ID: 12059854
    [No Abstract]   [Full Text] [Related]  

  • 35. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of Usher's syndrome associated with psychotic symptoms: diagnosis and follow-up in a psychiatric unit].
    Viala A; Nicot T; Levy F; Vacheron MN
    Encephale; 2009 Jun; 35(3):286-91. PubMed ID: 19540416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.
    Bowtell M; Eaton S; Thien K; Bardell-Williams M; Downey L; Ratheesh A; Killackey E; McGorry P; O'Donoghue B
    Schizophr Res; 2018 May; 195():231-236. PubMed ID: 29066258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine use in a forensic population in a New South Wales prison hospital.
    Martin A; O'Driscoll C; Samuels A
    Aust N Z J Psychiatry; 2008 Feb; 42(2):141-6. PubMed ID: 18197509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.